Pieris Pharmaceuticals: Q3 Earnings Snapshot
Pieris Pharmaceuticals Inc. (PIRS) on Wednesday reported a loss of $2.9 million in its third quarter. On a per-share basis, the Boston-based company said it had a loss of $2.19. This story was generated by Automated Insights ( using data from Zacks Investment Research.
Lifeway Foods has received a total of 1 ratings from analysts, with the consensus rating as Outperform. With an average ...
Financial writers report on the largest shareholders of Lifeway Foods urging the board to reconsider ...
GlobalData on MSN6dOpinion
Is Lifeway’s rejection of Danone bid shrewd or a gamble?Lifeway believes Danone’s offer undervalues its business. But will the French dairy giant return to the table?
On Sept. 23, Danone offered to pay some $283 million — $25 per share — to purchase the 76.6% of Lifeway Foods it does not ...
The Morton Grove-based kefir maker turned down Danone's offer, saying the $25-a-share deal undervalues the company.
GlobalData on MSN8d
Lifeway Foods rejects Danone’s takeover offer deemed as undervaluedLifeway Foods has rejected the takeover bid lodged by Danone in September as the US-based kefir maker deemed the offer to be ...
Lake Street analyst Ben Klieve assigned a Buy rating to Lifeway Foods (LWAY – Research Report) today and set a price target of $28.00.
Lifeway Foods Inc., Morton Grove, Ill., announced that its Board of Directors has rejected the unsolicited proposal made Sept ...
Lifeway Foods, Inc. (NASDAQ: LWAY) ("Lifeway" or the "Company"), a leading U.S. supplier of kefir and fermented probiotic ...
Lifeway Foods (LWAY) announced an expanded distribution agreement in the United Arab Emirates market. “The offering of 32oz Lifeway Kefir, 8oz Lactose-Free Lifeway Kefir, ProBugs and farmer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback